.jpeg&w=60&q=100&h=60)
The African Union (AU) has obtained 270 million vaccines against Covid-19 for the continent — as per a statement issued Wednesday evening by South African President Cyril Ramaphosa who also serves as the 15 nation bloc’s current head, “We have gone a step further to obtain vaccines independently using our own limited resources.”
The vaccines, of which at least 50 million will be available between April and June, will be supplied by the laboratories Pfizer-BioNTech, AstraZeneca — whose production is in India, and Johnson & Johnson.
Agreements to help African countries finance the purchase of these vaccines have been reached with the pan-African Afreximbank (Africa Export-Import Bank) and the World Bank.
Africa One of the Least Affected Areas in the World
Africa has so far been officially relatively spared by the pandemic as the continent has recorded just over 3 million cases and more than 74,000 deaths, according to official data.
Figures that pale in comparison to those of several European countries and the United States.
Nevertheless, several nations on the continent are facing a second wave of the epidemic — such as South Africa, which has been and still is the most affected country with more than 1.2 million cases and 35,000 deaths — accounting for the majority of Africa’s cases.
The Right to Have Access
The initiative launched by the AU is separate from the Covax scheme, the World Health Organisation (WHO) and private partners, for equitable access to vaccines.
The AU — on a mission to obtain vaccines, is holding discussions with other manufacturers to obtain even more as – as per the organisation’s official statement, “there is still a long way to go” to defeat the virus.
